Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PDUFA Budgeting: What Will Get Added, Subtracted – Or Multiplied By Cures?

This article was originally published in The Pink Sheet Daily

Executive Summary

Industry official sees potential for some streamlining in user fee program, but adding to breakthrough and patient-centered activities seems most likely.

Advertisement

Related Content

Senate Medical Innovation Bill: Will Slow, Small And Steady Win The Race?
PDUFA VI Might Adjust Establishment Fees; FDA Aims For Simplification
PDUFA VI Might Adjust Establishment Fees; FDA Aims For Simplification
PDUFA Negotiations Begin With FDA Seeking Review System Reform
PDUFA Negotiations Begin With FDA Seeking Review System Reform
Califf Nomination Adds New Dynamic, Maybe New Provisions, To FDA Reform Bills
Does PDUFA Need A Haircut? FDA Ponders Trimming Its Responsibilities
PDUFA VI: Price Tag For Patient Experience Data Validation May Go Up
FDA Central Review Likely For Novel Surrogate Endpoints
‘Breakthrough’ Fee Eyed As Deterrent To Frivolous Requests

Topics

Advertisement
UsernamePublicRestriction

Register

PS078928

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel